|
RCC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.70490313375649E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.85680000158928E-08 |
| Normal-vs-Stage2 |
4.398200E-03 |
| Normal-vs-Stage3 |
1.97420000003223E-06 |
| Normal-vs-Stage4 |
3.716900E-03 |
| Stage1-vs-Stage2 |
8.906600E-01 |
| Stage1-vs-Stage3 |
1.131560E-02 |
| Stage1-vs-Stage4 |
5.727900E-02 |
| Stage2-vs-Stage3 |
3.892400E-02 |
| Stage2-vs-Stage4 |
2.709500E-02 |
| Stage3-vs-Stage4 |
5.631800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14170006781933E-10 |
| Normal-vs-AfricanAmerican |
8.77710000013465E-07 |
| Normal-vs-Asian |
6.459800E-02 |
| Caucasian-vs-AfricanAmerican |
2.801400E-01 |
| Caucasian-vs-Asian |
6.755800E-01 |
| AfricanAmerican-vs-Asian |
3.369200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.67389999031309E-10 |
| Normal-vs-Female |
5.38699995722425E-09 |
| Male-vs-Female |
2.146000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.22159999999638E-05 |
| Normal-vs-Extreme_Weight |
9.56419999864622E-08 |
| Normal-vs-Obese |
7.63719999463675E-08 |
| Normal-vs-Extreme_Obese |
2.367800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.472600E-01 |
| Normal_Weight-vs-Obese |
2.317000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.798200E-01 |
| Extreme_Weight-vs-Obese |
3.602400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.882600E-01 |
| Obese-vs-Extreme_Obese |
1.682840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.423470E-04 |
| Normal-vs-Age(41-60Yrs) |
2.33249974890271E-10 |
| Normal-vs-Age(61-80Yrs) |
8.43619996082623E-09 |
| Normal-vs-Age(81-100Yrs) |
2.563200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.234300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.977800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.158600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.591600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.451900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.747800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.1518999632496E-09 |
| Normal-VS-Type2 PRCC |
1.27800000004896E-06 |
| Normal-VS-KIRP CIMP |
5.59629999999922E-05 |
| Normal-VS-Unclassified PRCC |
4.31759999974801E-08 |
| Type1 PRCC-VS-Type2 PRCC |
5.717200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.809100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.522400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.350300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.659800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.038000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.94521999999919E-05 |
| Normal-vs-N1 |
2.87009999999643E-06 |
| Normal-vs-N2 |
7.691800E-02 |
| N0-vs-N1 |
2.541100E-03 |
| N0-vs-N2 |
4.164300E-02 |
| N1-vs-N2 |
8.961000E-01 |
|
|
